摘要
近年来,我国广泛开展中医药干预多病种的临床随机对照试验,其中随机化设计尤为重要。但是,我国中医药临床随机对照试验的方法学与报告质量普遍不高,尤其是在随机化方面认识不足。对于随机化分配方法、分配隐匿的了解较差,实施不严格。本文在梳理国内外临床试验中的随机化理论、随机化分配方法、分配隐匿方法的基础上,针对我国中医药临床随机对照试验中在随机化方面出现的问题进行阐述并深入思考,为规范临床试验的随机化过程提出可行性建议。
Recently,the randomized controlled trials(RCTs)in traditional Chinese medicine(TCM)intervention in multiple diseases have been widely developed in China,in which randomization plays an irreplaceable role.However,the methodology and reports of RCTs in TCM still keep a poor quality,specifically the lack of awareness of randomization.Most researchers know little about randomized methods and allocation concealment,and have no strict implementation.Therefore,on the basis of reviewing the randomization theory in clinical trials at home and abroad,the randomization allocation method and the allocation concealment method,the problems of randomization in clinical RCTs of TCM in China were expounded and deeply considered.This paper suggested feasibility ideas to standardize the randomization process of clinical trials.
作者
李洪峥
李博
赵国桢
LI Hong-zheng;LI Bo;ZHAO Guo-zhen(Beijing Institute of Traditional Chinese Medicine,Beijing 100010,China;Beijing Hospital of Traditional Chinese Medicine,Beijing 100010,China;Beijing University of Chinese Medicine,Beijing 100029,China;Guang'anmen Hospital,China Academy of Chinese Medical Sciences,Beijing 100053,China)
出处
《中国新药杂志》
CAS
CSCD
北大核心
2019年第11期1348-1354,共7页
Chinese Journal of New Drugs
基金
国家自然科学基金项目(81774146)
北京市科技新星计划资助项目(xxjh2015A093,Z1511000003150125)
北京市属医学科研院所科技发展项目(PXM2017-026273-000003)
关键词
随机化
中医药
药物临床试验
规范化
randomization
traditional Chinese medicine
clinical trials
standardization